DK2300424T3 - Anvendelse af indolderivater som NURR-1-aktivatorer til behandling af Parkinsons sygdom - Google Patents

Anvendelse af indolderivater som NURR-1-aktivatorer til behandling af Parkinsons sygdom

Info

Publication number: DK2300424T3
Authority: DK; Denmark
Prior art keywords: nurr; activators; parkinson; disease; treatment
Prior art date: 2008-07-10

Application number

DK09784501.0T

Other languages

English (en)

Inventor

Benaissa Boubia

Vliet Bernard Johannes Van

Hartog Jacobus Antonius Joseph Den

Andrew Mccreary

Mireille Tallandier

Dongen Maria Johanna Petronella Van

Olivia Poupardin-Olivier

Original Assignee

Fournier Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-10

Filing date

2009-07-09

Publication date

2012-04-16

2009-07-09 Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa

2012-04-16 Application granted granted Critical

2012-04-16 Publication of DK2300424T3 publication Critical patent/DK2300424T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK09784501.0T 2008-07-10 2009-07-09 Anvendelse af indolderivater som NURR-1-aktivatorer til behandling af Parkinsons sygdom DK2300424T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0854712A FR2933609B1 (fr)	2008-07-10	2008-07-10	Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
PCT/FR2009/051372 WO2010004221A2 (fr)	2008-07-10	2009-07-09	Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson

Publications (1)

Publication Number	Publication Date
DK2300424T3 true DK2300424T3 (da)	2012-04-16

Family

ID=40297845

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09784501.0T DK2300424T3 (da)	2008-07-10	2009-07-09	Anvendelse af indolderivater som NURR-1-aktivatorer til behandling af Parkinsons sygdom

Country Status (28)

Country	Link
US (1)	US8575210B2 (da)
EP (1)	EP2300424B1 (da)
JP (1)	JP5396650B2 (da)
KR (1)	KR101606184B1 (da)
CN (1)	CN102112441B (da)
AR (1)	AR072718A1 (da)
AT (1)	ATE541831T1 (da)
AU (1)	AU2009269842B2 (da)
BR (1)	BRPI0915627A8 (da)
CA (1)	CA2730302C (da)
CY (1)	CY1112638T1 (da)
DK (1)	DK2300424T3 (da)
EA (1)	EA018079B1 (da)
ES (1)	ES2381180T3 (da)
FR (1)	FR2933609B1 (da)
HK (1)	HK1154852A1 (da)
HR (1)	HRP20120231T1 (da)
IL (1)	IL210386A (da)
MX (1)	MX2011000353A (da)
MY (1)	MY155959A (da)
PL (1)	PL2300424T3 (da)
PT (1)	PT2300424E (da)
SA (1)	SA109300453B1 (da)
SI (1)	SI2300424T1 (da)
TW (1)	TWI414289B (da)
UA (1)	UA102397C2 (da)
WO (1)	WO2010004221A2 (da)
ZA (1)	ZA201100041B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2955108B1 (fr) *	2010-01-08	2012-03-16	Fournier Lab Sa	Utilisation de derives de pyrrolopyridine comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
EP2487159A1 (en) *	2011-02-11	2012-08-15	MSD Oss B.V.	RorgammaT inhibitors
WO2013029338A1 (en) *	2011-09-01	2013-03-07	Glaxo Group Limited	Novel compounds
KR101964889B1 (ko)	2017-11-17	2019-04-02	한국생명공학연구원	다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물
WO2019098699A1 (ko)	2017-11-15	2019-05-23	한국생명공학연구원	다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물
KR102059160B1 (ko)	2017-11-15	2019-12-24	한국생명공학연구원	다프난 또는 포볼 다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물
KR20240020098A (ko)	2022-08-05	2024-02-14	엠테라파마 주식회사	다이터펜계 화합물을 포함하는 신경퇴행성 질환 예방 또는 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE297910T1 (de) *	2001-03-14	2005-07-15	Lilly Co Eli	Retinoid x rezeptormodulatoren
GB0119911D0 (en) *	2001-08-15	2001-10-10	Novartis Ag	Organic Compounds
GB0303503D0 (en)	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
WO2005056522A2 (en) *	2003-12-04	2005-06-23	National Health Research Institutes	Indole compounds
FR2890071B1 (fr) *	2005-08-30	2007-11-09	Fournier Sa Sa Lab	Nouveaux composes de l'indole
FR2903107B1 (fr)	2006-07-03	2008-08-22	Sanofi Aventis Sa	Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903105A1 (fr)	2006-07-03	2008-01-04	Sanofi Aventis Sa	Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
FR2903106B1 (fr)	2006-07-03	2010-07-30	Sanofi Aventis	Utilisations de 2-benzoyl-imidazopyridines en therapeutique
FR2906250B1 (fr)	2006-09-22	2008-10-31	Sanofi Aventis Sa	Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique

2008
- 2008-07-10 FR FR0854712A patent/FR2933609B1/fr not_active Expired - Fee Related
2009
- 2009-07-08 AR ARP090102577A patent/AR072718A1/es unknown
- 2009-07-08 SA SA109300453A patent/SA109300453B1/ar unknown
- 2009-07-09 DK DK09784501.0T patent/DK2300424T3/da active
- 2009-07-09 AT AT09784501T patent/ATE541831T1/de active
- 2009-07-09 KR KR1020117000129A patent/KR101606184B1/ko not_active IP Right Cessation
- 2009-07-09 UA UAA201100224A patent/UA102397C2/ru unknown
- 2009-07-09 ES ES09784501T patent/ES2381180T3/es active Active
- 2009-07-09 CA CA2730302A patent/CA2730302C/fr not_active Expired - Fee Related
- 2009-07-09 AU AU2009269842A patent/AU2009269842B2/en not_active Ceased
- 2009-07-09 EA EA201170150A patent/EA018079B1/ru not_active IP Right Cessation
- 2009-07-09 WO PCT/FR2009/051372 patent/WO2010004221A2/fr active Application Filing
- 2009-07-09 US US13/003,554 patent/US8575210B2/en not_active Expired - Fee Related
- 2009-07-09 BR BRPI0915627A patent/BRPI0915627A8/pt not_active IP Right Cessation
- 2009-07-09 MX MX2011000353A patent/MX2011000353A/es active IP Right Grant
- 2009-07-09 CN CN2009801269277A patent/CN102112441B/zh not_active Expired - Fee Related
- 2009-07-09 SI SI200930209T patent/SI2300424T1/sl unknown
- 2009-07-09 PT PT09784501T patent/PT2300424E/pt unknown
- 2009-07-09 JP JP2011517215A patent/JP5396650B2/ja not_active Expired - Fee Related
- 2009-07-09 PL PL09784501T patent/PL2300424T3/pl unknown
- 2009-07-09 MY MYPI2011000084A patent/MY155959A/en unknown
- 2009-07-09 EP EP09784501A patent/EP2300424B1/fr not_active Not-in-force
- 2009-07-10 TW TW098123503A patent/TWI414289B/zh not_active IP Right Cessation
2010
- 2010-12-30 IL IL210386A patent/IL210386A/en not_active IP Right Cessation
2011
- 2011-01-03 ZA ZA2011/00041A patent/ZA201100041B/en unknown
- 2011-08-29 HK HK11109072.9A patent/HK1154852A1/xx not_active IP Right Cessation
2012
- 2012-03-13 HR HR20120231T patent/HRP20120231T1/hr unknown
- 2012-03-14 CY CY20121100267T patent/CY1112638T1/el unknown

Also Published As

Publication number	Publication date
EA018079B1 (ru)	2013-05-30
ZA201100041B (en)	2012-03-28
IL210386A0 (en)	2011-03-31
MX2011000353A (es)	2011-02-22
BRPI0915627A8 (pt)	2017-05-16
CN102112441A (zh)	2011-06-29
FR2933609A1 (fr)	2010-01-15
HK1154852A1 (en)	2012-05-04
EP2300424B1 (fr)	2012-01-18
ATE541831T1 (de)	2012-02-15
IL210386A (en)	2015-09-24
HRP20120231T1 (hr)	2012-04-30
CY1112638T1 (el)	2016-02-10
US8575210B2 (en)	2013-11-05
AR072718A1 (es)	2010-09-15
EA201170150A1 (ru)	2011-06-30
FR2933609B1 (fr)	2010-08-27
CA2730302A1 (fr)	2010-01-14
AU2009269842A1 (en)	2010-01-14
JP5396650B2 (ja)	2014-01-22
CN102112441B (zh)	2013-07-10
ES2381180T3 (es)	2012-05-23
EP2300424A2 (fr)	2011-03-30
UA102397C2 (ru)	2013-07-10
MY155959A (en)	2015-12-31
AU2009269842B2 (en)	2013-08-22
SI2300424T1 (sl)	2012-04-30
JP2011527326A (ja)	2011-10-27
KR20110110759A (ko)	2011-10-07
PT2300424E (pt)	2012-04-27
SA109300453B1 (ar)	2013-05-18
KR101606184B1 (ko)	2016-03-24
US20110178150A1 (en)	2011-07-21
WO2010004221A3 (fr)	2010-05-06
PL2300424T3 (pl)	2012-06-29
WO2010004221A2 (fr)	2010-01-14
BRPI0915627A2 (pt)	2016-07-26
CA2730302C (fr)	2017-03-07
TWI414289B (zh)	2013-11-11
TW201006468A (en)	2010-02-16

Publication	Publication Date	Title
DK2303330T4 (da)	2021-09-13	Farmaceutiske sammensætninger til behandling af parkinsons sygdom
HK1200169A1 (en)	2015-07-31	Compounds used in the synthesis of oxazolidinones
DK3309139T3 (da)	2023-12-18	Process for the preparation of 2,3,3,3-trifluoropropene
FR2933281B1 (fr)	2011-12-30	Applicateur d'eyeliner
BRPI0916123A2 (pt)	2015-11-03	"composição de xampu concentrada"
ATE555107T1 (de)	2012-05-15	2-aza-bicyclo-ä2,2,1-üheptan-derivate
FI20085213A0 (fi)	2008-03-07	Pigmenttipartikkelikoostumus, menetelmä sen valmistamiseksi sekä sen käyttö
DE602005027307D1 (de)	2011-05-19	Arylanilinderivate als agonisten des beta2-adrenergen rezeptors
EP2222659A4 (en)	2011-05-04	INDOLE, DERIVATIVES AND ANALOGUE THEREOF AND APPLICATIONS THEREOF
IT1395519B1 (it)	2012-09-28	Pezzo composito, nonche' impiego del pezzo composito
DK2344146T3 (da)	2013-07-08	Anticonnexin-midler til anvendelse til modulering af psykotrope molekylers terapeutiske virkning
MY149705A (en)	2013-09-30	Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
DK2146991T3 (da)	2010-11-22	Triazolopyridin-carboxamid-derivater, fremstilling af samme samt terapeutisk anvendelse deraf
DK2300424T3 (da)	2012-04-16	Anvendelse af indolderivater som NURR-1-aktivatorer til behandling af Parkinsons sygdom
BRPI0914533A2 (pt)	2015-12-15	"métodos"
BRPI0916363A2 (pt)	2018-05-29	derivados de 4,5-di-hidro-oxazol-2-ila
ZA201103727B (en)	2014-11-26	Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine
ATE540023T1 (de)	2012-01-15	Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
BRPI0821026A2 (pt)	2015-06-16	Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
EP2361907A4 (en)	2012-07-25	THE FIVE CRYSTALLINE FORMS OF NICOUSAMIDE, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
PL2242491T3 (pl)	2012-12-31	Nowatorskie zastosowanie 3,3'-diinodolilometanu
BRPI0919816A2 (pt)	2019-09-24	uso compostos benzoxazólicos no tratamento de malária
IT1393508B1 (it)	2012-04-27	Dicarba-analoghi dell'octreotide
IL218526A0 (en)	2012-07-31	Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
BRPI0906053A2 (pt)	2015-06-30	"enzima artificial"